Sorry, you need to enable JavaScript to visit this website.

You are here


Our biopharmaceutical businesses include our Global Innovative Products, and Vaccines and Oncology businesses, and our Global Established Products business.

These businesses are generally responsible for late-stage clinical development of medicines that have advanced to at least phase 2b of clinical development, having achieved earlier stages of pre-identified safety and efficacy measures. 

With each business focusing on global but specific areas of medicine and related-services, our unique structure allows us to be more responsive and flexible to the needs of our partners.


Global Innovative Products

Global Innovative Products is focused on prosecuting new, investigational medicines across Pfizer's therapeutic areas of interest.



Pfizer's Vaccines business is one of the industry’s largest, with more than $4 billion in global revenue.



Pfizer Oncology is striving to cure or control cancer with innovative medicines.


Global Established Products

Global Established Products has more than 600 branded and generic products in its portfolio.


Connect With Us


Reach out. We want to hear from you.

Submit Your Opportunity


Send us your innovative ideas today.